showed a trendp=0.08
Xanamem showed a trend towards higher response rates at Week 10 (50% MADRS reduction, 34% Xanamem vs. 22% placebo, p=0.08).
Xanamem showed a trend towards higher response rates at Week 10 (50% MADRS reduction, 34% Xanamem vs. 22% placebo, p=0.08).